Annual EBIT
-$21.16 M
+$16.20 M+43.36%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual earnings before interest & taxes is -$21.16 million, with the most recent change of +$16.20 million (+43.36%) on December 31, 2023.
- During the last 3 years, COEP annual EBIT has fallen by -$12.15 million (-134.89%).
- COEP annual EBIT is now -134.89% below its all-time high of -$9.01 million, reached on December 1, 2020.
Performance
COEP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.78 M
+$1.19 M+40.12%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly earnings before interest & taxes is -$1.78 million, with the most recent change of +$1.19 million (+40.12%) on September 1, 2024.
- Over the past year, COEP quarterly EBIT has increased by +$1.96 million (+52.48%).
- COEP quarterly EBIT is now at all-time high.
Performance
COEP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$11.29 M
+$4.55 M+28.74%
September 1, 2024
Summary
- As of February 8, 2025, COEP TTM earnings before interest & taxes is -$11.29 million, with the most recent change of +$4.55 million (+28.74%) on September 1, 2024.
- Over the past year, COEP TTM EBIT has increased by +$9.87 million (+46.64%).
- COEP TTM EBIT is now -489.46% below its all-time high of -$1.92 million, reached on March 1, 2021.
Performance
COEP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
COEP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.4% | +52.5% | +46.6% |
| 3 y3 years | -134.9% | +81.7% | +69.9% |
| 5 y5 years | -134.9% | +81.7% | +69.9% |
COEP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -59.5% | +43.4% | at high | +90.7% | at high | +69.9% |
| 5 y | 5-year | -134.9% | +43.4% | at high | +90.7% | -489.5% | +69.9% |
| alltime | all time | -134.9% | +43.4% | at high | +90.7% | -489.5% | +69.9% |
Coeptis Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.78 M(-40.1%) | -$11.29 M(-28.7%) |
| Jun 2024 | - | -$2.97 M(+6.0%) | -$15.84 M(-1.2%) |
| Mar 2024 | - | -$2.80 M(-25.1%) | -$16.03 M(-24.2%) |
| Dec 2023 | -$21.16 M(-43.4%) | -$3.74 M(-40.9%) | -$21.16 M(+4.1%) |
| Sep 2023 | - | -$6.33 M(+100.3%) | -$20.32 M(+3.8%) |
| Jun 2023 | - | -$3.16 M(-60.1%) | -$19.58 M(-25.2%) |
| Mar 2023 | - | -$7.93 M(+173.3%) | -$26.16 M(-30.0%) |
| Dec 2022 | -$37.36 M | -$2.90 M(-48.1%) | -$37.36 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$5.59 M(-42.6%) | -$37.37 M(-0.4%) |
| Jun 2022 | - | -$9.74 M(-49.1%) | -$37.54 M(+23.2%) |
| Mar 2022 | - | -$19.12 M(+555.2%) | -$30.47 M(+129.8%) |
| Dec 2021 | -$13.26 M(+47.2%) | - | - |
| Dec 2021 | - | -$2.92 M(-49.3%) | -$13.26 M(+28.2%) |
| Sep 2021 | - | -$5.76 M(+115.6%) | -$10.34 M(+125.6%) |
| Jun 2021 | - | -$2.67 M(+39.4%) | -$4.59 M(+139.4%) |
| Mar 2021 | - | -$1.92 M | -$1.92 M |
| Dec 2020 | -$9.01 M | - | - |
FAQ
- What is Coeptis Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual EBIT year-on-year change?
- What is Coeptis Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly EBIT year-on-year change?
- What is Coeptis Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Coeptis Therapeutics?
- What is Coeptis Therapeutics TTM EBIT year-on-year change?
What is Coeptis Therapeutics annual earnings before interest & taxes?
The current annual EBIT of COEP is -$21.16 M
What is the all time high annual EBIT for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual earnings before interest & taxes is -$9.01 M
What is Coeptis Therapeutics annual EBIT year-on-year change?
Over the past year, COEP annual earnings before interest & taxes has changed by +$16.20 M (+43.36%)
What is Coeptis Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of COEP is -$1.78 M
What is the all time high quarterly EBIT for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly earnings before interest & taxes is -$1.78 M
What is Coeptis Therapeutics quarterly EBIT year-on-year change?
Over the past year, COEP quarterly earnings before interest & taxes has changed by +$1.96 M (+52.48%)
What is Coeptis Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of COEP is -$11.29 M
What is the all time high TTM EBIT for Coeptis Therapeutics?
Coeptis Therapeutics all-time high TTM earnings before interest & taxes is -$1.92 M
What is Coeptis Therapeutics TTM EBIT year-on-year change?
Over the past year, COEP TTM earnings before interest & taxes has changed by +$9.87 M (+46.64%)